DRKS00024787尚未招募未知
Pilot study to analyze COVID-19 vaccination response
Medizinische Klinik 3, Universitätsklinikum Erlangen0 个研究点目标入组 60 人开始时间: 2021年5月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Complete SARS-CoV-2 vaccination status
- •- Healthy volunteer or patient with inflammatory disease
排除标准
- •The patient is unwilling or unable to participate in the study
研究者
相似试验
尚未招募
不适用
To study the vaccination benefits among health care workers at a tertiary care hospitalCTRI/2021/07/034669Sushmitha Sen C
招募中
2 期
The evaluation of the effect of COVID-19 vaccination on calprotectin levels in IBD patientsIRCT20210113050024N3Esfahan University of Medical Sciences30
进行中（未招募）
不适用
Safety and reactogenicity of GSK Biologicals’ DTPa-IPV/Hib (Infanrix-IPV/Hib) in infants.Healthy volunteers (Primary immunisation of healthy infants in the first year of life against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b diseases).EUCTR2015-001513-27-Outside-EU/EEAGlaxoSmithKline Biologicals50
进行中（未招募）
1 期
Pneumococcal vaccine against atherosclerosisHealthy male volunteersMedDRA version: 19.0Level: LLTClassification code 10003601Term: AtherosclerosisSystem Organ Class: 100000004866EUCTR2015-005650-35-NLCentre for Human Drug Research24
已完成
2 期
Proof-of-pharmacology clinical trial on a vaccine that elicits a protective humoral immune response against oxidized low density lipoproteiHypercholesterolemie10003216AtherosclerosisNL-OMON43410Centre for Human Drug Research24